Crizocare (Crizotinib) 250mg Capsules | ElementoPharma Laos Generic Xalkori for ALK+ NSCLC | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Делиться
Product description

Generic Information: Crizocare (Crizotinib) Capsules 250 mg — ElementoPharma

Crizocare is the crizotinib 250 mg capsule brand of ElementoPharma, based in Boten, Luang Namtha province — Laos' northern border zone, where special-economic-zone logistics link directly into China's express networks. Each Crizocare pack holds 60 capsules at 250 mg, presented in a white screw-cap bottle with an outer carton bearing the manufacturer's molecular-design logo and full contact details.

What Is Crizocare For?

Crizocare provides crizotinib therapy for advanced NSCLC whose tumors are ALK-rearranged or ROS1-rearranged on validated molecular testing. Internationally recognized reference uses of the molecule extend to ALK-positive systemic anaplastic large cell lymphoma in children one year and older and young adults, and to ALK-positive inflammatory myofibroblastic tumor that is unresectable, recurrent or refractory. GLT supports documentation for these broader indications when a treating physician requests it.

How Does Crizocare Work in the Body?

Crizotinib is an oral blocker of the ALK, ROS1, c-Met and RON kinase family. Fusion proteins born from ALK or ROS1 gene rearrangements behave like permanently pressed accelerators inside tumor cells; by occupying the kinases' ATP pockets, crizotinib lifts the foot off, collapsing downstream survival signaling and steering those cells back toward natural death pathways. Only molecularly positive tumors respond — testing is the gatekeeper.

Indications Summary

  • ALK-rearranged locally advanced or metastatic non-small cell lung cancer
  • ROS1-rearranged advanced non-small cell lung cancer
  • Reference uses: ALK-positive ALCL (age ≥1 year and young adults) and ALK-positive IMT

Dosage Instructions

Adults follow the classic schedule: one 250 mg capsule twice daily about twelve hours apart, meals optional, grapefruit excluded. Swallow capsules whole with water. When monitoring reveals toxicity, oncologists step the dose down through available lower strengths; severe renal impairment without dialysis moves the routine to once daily. The regimen continues until progression or unacceptable intolerance.

Side Effects to Expect

Frequently seen: brief visual phenomena such as light trails, nausea, diarrhea, constipation, vomiting, mild ankle swelling and tiredness, alongside rising transaminases on routine labs. The serious watch-list includes liver injury, interstitial lung disease or pneumonitis, QT prolongation, bradycardia and marked visual deterioration. Scheduled liver panels and ECGs, plus early dose adjustments, form the safety net that keeps most patients on track.

Storage Directions

Keep the bottle below 30°C, tightly closed, in its original carton away from damp. No refrigeration or cold-chain logistics are involved at any point from Vientiane to your door.

Why Choose the GLT?

ElementoPharma is a newer generation Lao producer whose Boten location gives it unusually fast resupply lines, but buyers abroad still need someone trustworthy on the ground. GLT plays that role: a Hong Kong licensed wholesaler with direct sourcing, written batch and expiry disclosure, pre-dispatch stock photos, honest customs declarations and end-to-end tracking. One family's course or a clinic's standing order — both move through the same verified, documented channel.

How to Order Crizocare from GLT

WhatsApp GLT at +86 15234153837 or email [email protected] with your prescription and genetic test report. We quote the 60-capsule Crizocare pack, confirm current stock and batch, and arrange insured, trackable worldwide shipping with complete paperwork.

FAQ

Q1: What is Crizocare 250 mg?
ElementoPharma's crizotinib capsule — a Lao-manufactured generic of the first-generation ALK/ROS1 inhibitor, 60 capsules per bottle.

Q2: Who is the manufacturer behind Crizocare?
ElementoPharma Co., Ltd, based in Boten, Luang Namtha, Laos.

Q3: Is Crizocare cheaper than the originator?
Substantially — Lao generics trade far below Western brand pricing; GLT provides current quotes on request.

Q4: Where can I buy Crizocare capsules?
Through GLT: WhatsApp +86 15234153837 or [email protected], with your prescription and test report.

Q5: How is Crizocare shipped?
Ambient-temperature express with tracking — the capsules need only dry storage below 30°C.

Related Oncology Products

Tixepa (Тирзепатид) 20мг/2мл и 30мг/2мл многодозовая ручка | Drug International | GLT

Tixepa — многодозовая ручка тирзепатида Drug International Limited (DIL), две официальные дозировки (Tixepa-5 = 20мг/2мл,...

Palutini (Барицитиниб) 4мг | Дженерик-ингибитор JAK1/JAK2 | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Trans Continental Life Science & Pharmaceuticals (TLPH) (Лаос) — доступная...

KeZeRui 科瑞泽 (Аватромбопаг) 20мг*10 таб. | Sichuan Kelun (Китай) | GLT

KeZeRui — аватромбопаг национальной закупки от Sichuan Kelun Pharmaceutical, интегрированного китайского производителя АФС и таблеток.

Baricent (Барицитиниб) 2мг | Дженерик-ингибитор JAK1/JAK2 | Incepta Pharmaceuticals Ltd. | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Incepta Pharmaceuticals Ltd. (Бангладеш) — доступная альтернатива Olumiant при ревматоидном...

Barinib (Барицитиниб) 2мг | Дженерик-ингибитор JAK1/JAK2 | Drug International Limited | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Drug International Limited (Бангладеш) — доступная альтернатива Olumiant при ревматоидном...

Элтромбопаг (Promacta) 25мг/50мг таблетки | Оригинальный TPO-R агонист из США | GLT

Оригинальный Promacta (элтромбопаг) от Novartis, 25 мг и 50 мг, 30 таблеток

SPINRAZA (Нусинерсен) 12 мг/5 мл | Покупка из Китая | Терапия СМА | GLT

Первый в своём классе антисмысловой олигонуклеотид Biogen для лечения СМА, одобренный NMPA и возмещаемый в...

Barinat (Барицитиниб) 4мг | Дженерик-ингибитор JAK1/JAK2 | Natco Pharma Limited | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Natco Pharma Limited (Индия) — доступная альтернатива Olumiant при ревматоидном...